These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 22968701)

  • 1. TGFβ induces the formation of tumour-initiating cells in claudinlow breast cancer.
    Bruna A; Greenwood W; Le Quesne J; Teschendorff A; Miranda-Saavedra D; Rueda OM; Sandoval JL; Vidakovic AT; Saadi A; Pharoah P; Stingl J; Caldas C
    Nat Commun; 2012; 3():1055. PubMed ID: 22968701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of cell lines derived from breast cancers and normal mammary tissues for the study of the intrinsic molecular subtypes.
    Prat A; Karginova O; Parker JS; Fan C; He X; Bixby L; Harrell JC; Roman E; Adamo B; Troester M; Perou CM
    Breast Cancer Res Treat; 2013 Nov; 142(2):237-55. PubMed ID: 24162158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A basal-like breast cancer-specific role for SRF-IL6 in YAP-induced cancer stemness.
    Kim T; Yang SJ; Hwang D; Song J; Kim M; Kyum Kim S; Kang K; Ahn J; Lee D; Kim MY; Kim S; Seung Koo J; Seok Koh S; Kim SY; Lim DS
    Nat Commun; 2015 Dec; 6():10186. PubMed ID: 26671411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor-beta signaling: emerging stem cell target in metastatic breast cancer?
    Tan AR; Alexe G; Reiss M
    Breast Cancer Res Treat; 2009 Jun; 115(3):453-95. PubMed ID: 18841463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclic AMP enhances TGFβ responses of breast cancer cells by upregulating TGFβ receptor I expression.
    Oerlecke I; Bauer E; Dittmer A; Leyh B; Dittmer J
    PLoS One; 2013; 8(1):e54261. PubMed ID: 23349840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-31 promotes mammary stem cell expansion and breast tumorigenesis by suppressing Wnt signaling antagonists.
    Lv C; Li F; Li X; Tian Y; Zhang Y; Sheng X; Song Y; Meng Q; Yuan S; Luan L; Andl T; Feng X; Jiao B; Xu M; Plikus MV; Dai X; Lengner C; Cui W; Ren F; Shuai J; Millar SE; Yu Z
    Nat Commun; 2017 Oct; 8(1):1036. PubMed ID: 29051494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD49f and CD61 identify Her2/neu-induced mammary tumor-initiating cells that are potentially derived from luminal progenitors and maintained by the integrin-TGFβ signaling.
    Lo PK; Kanojia D; Liu X; Singh UP; Berger FG; Wang Q; Chen H
    Oncogene; 2012 May; 31(21):2614-26. PubMed ID: 21996747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autocrine CSF1R signaling mediates switching between invasion and proliferation downstream of TGFβ in claudin-low breast tumor cells.
    Patsialou A; Wang Y; Pignatelli J; Chen X; Entenberg D; Oktay M; Condeelis JS
    Oncogene; 2015 May; 34(21):2721-31. PubMed ID: 25088194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGFbeta/TNF(alpha)-mediated epithelial-mesenchymal transition generates breast cancer stem cells with a claudin-low phenotype.
    Asiedu MK; Ingle JN; Behrens MD; Radisky DC; Knutson KL
    Cancer Res; 2011 Jul; 71(13):4707-19. PubMed ID: 21555371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NEDD9 is a positive regulator of epithelial-mesenchymal transition and promotes invasion in aggressive breast cancer.
    Kong C; Wang C; Wang L; Ma M; Niu C; Sun X; Du J; Dong Z; Zhu S; Lu J; Huang B
    PLoS One; 2011; 6(7):e22666. PubMed ID: 21829474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PARP3 controls TGFβ and ROS driven epithelial-to-mesenchymal transition and stemness by stimulating a TG2-Snail-E-cadherin axis.
    Karicheva O; Rodriguez-Vargas JM; Wadier N; Martin-Hernandez K; Vauchelles R; Magroun N; Tissier A; Schreiber V; Dantzer F
    Oncotarget; 2016 Sep; 7(39):64109-64123. PubMed ID: 27579892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted Pten deletion plus p53-R270H mutation in mouse mammary epithelium induces aggressive claudin-low and basal-like breast cancer.
    Wang S; Liu JC; Kim D; Datti A; Zacksenhaus E
    Breast Cancer Res; 2016 Jan; 18(1):9. PubMed ID: 26781438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APPL proteins promote TGFβ-induced nuclear transport of the TGFβ type I receptor intracellular domain.
    Song J; Mu Y; Li C; Bergh A; Miaczynska M; Heldin CH; Landström M
    Oncotarget; 2016 Jan; 7(1):279-92. PubMed ID: 26583432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mammary cellular hierarchy and breast cancer.
    Oakes SR; Gallego-Ortega D; Ormandy CJ
    Cell Mol Life Sci; 2014 Nov; 71(22):4301-24. PubMed ID: 25080108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Six1 in luminal breast cancers predicts poor prognosis and promotes increases in tumor initiating cells by activation of extracellular signal-regulated kinase and transforming growth factor-beta signaling pathways.
    Iwanaga R; Wang CA; Micalizzi DS; Harrell JC; Jedlicka P; Sartorius CA; Kabos P; Farabaugh SM; Bradford AP; Ford HL
    Breast Cancer Res; 2012 Jul; 14(4):R100. PubMed ID: 22765220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer anti-estrogen resistance 3 inhibits transforming growth factor β/Smad signaling and associates with favorable breast cancer disease outcomes.
    Guo J; Canaff L; Rajadurai CV; Fils-Aimé N; Tian J; Dai M; Korah J; Villatoro M; Park M; Ali S; Lebrun JJ
    Breast Cancer Res; 2014 Dec; 16(6):476. PubMed ID: 25499443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progesterone regulation of stem and progenitor cells in normal and malignant breast.
    Axlund SD; Sartorius CA
    Mol Cell Endocrinol; 2012 Jun; 357(1-2):71-9. PubMed ID: 21945473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancers, mammary stem cells, and cancer stem cells, characteristics, and hypotheses.
    Taurin S; Alkhalifa H
    Neoplasia; 2020 Dec; 22(12):663-678. PubMed ID: 33142233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small molecule antagonists of the Wnt/β-catenin signaling pathway target breast tumor-initiating cells in a Her2/Neu mouse model of breast cancer.
    Hallett RM; Kondratyev MK; Giacomelli AO; Nixon AM; Girgis-Gabardo A; Ilieva D; Hassell JA
    PLoS One; 2012; 7(3):e33976. PubMed ID: 22470504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ATF3, an adaptive-response gene, enhances TGF{beta} signaling and cancer-initiating cell features in breast cancer cells.
    Yin X; Wolford CC; Chang YS; McConoughey SJ; Ramsey SA; Aderem A; Hai T
    J Cell Sci; 2010 Oct; 123(Pt 20):3558-65. PubMed ID: 20930144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.